Human Carboxypeptidase A1/CPA1 PharmaGenie ELISA Kit (SBRS0344)

The Assay Genie kit for human Carboxypeptidase A1 (CPA1) is a quantitative immunoassay for research use only, supporting studies on this pancreatic zinc metalloprotease that cleaves C-terminal aromatic and branched-chain residues during the final stages of dietary protein breakdown. Mutations in the CPA1 gene have been linked to hereditary pancreatitis susceptibility, and altered circulating enzyme levels have been investigated in the context of pancreatic ductal adenocarcinoma and other exocrine disorders. The immunoassay measures human CPA1 in conditioned cell culture medium and in clinical samples, run on a standard microplate platform with a colorimetric endpoint read on conventional plate readers. Researchers studying acinar cell stress, pancreatic injury, or digestive-enzyme homeostasis can apply it to disease models and clinical cohorts. The assay is calibrated specifically for the human target, providing the resolution needed to detect subtle changes in CPA1 expression across experimental conditions.